We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M Turnover 23.21%
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$170M
AUM Growth
-$12.7M
Cap. Flow
-$12.5M
Cap. Flow %
-7.34%
Top 10 Hldgs %
60.5%
Holding
104
New
11
Increased
13
Reduced
10
Closed
4
Avg Time Held
3 years
Top 10 Avg Time Held
1.6 years
Top 20 Avg Time Held
1.5 years

Top Buys

Rank Stock Value
1
VAPO
Vapotherm, Inc. Common Stock
VAPO
+$1.77M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$1.29M
3
TGTX icon
TG Therapeutics
TGTX
+$892K
4
KYNB icon
Kyntra Bio
KYNB
+$849K
5
GILD icon
Gilead Sciences
GILD
+$763K

Top Sells

Rank Stock Value
1
SRCL icon
Stericycle Inc
SRCL
+$6.7M
2
CCXI icon
ChemoCentryx, Inc.
CCXI
+$3.69M
3
KKR icon
KKR & Co
KKR
+$2.8M
4
LGND icon
Ligand Pharmaceuticals
LGND
+$2.73M
5
BLU
BELLUS Health Inc.
BLU
+$2.47M

Sector Composition

Rank Sector Weight
1 Healthcare 41.75%
2 Financials 15.96%
3 Industrials 12.97%
4 Technology 9.76%
5 Communication Services 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AAPL icon
51
Apple
AAPL
$5.01T
$486K 0.29%
4,200
– –
2013 Q2
29 quarters
RHP icon
52
Ryman Hospitality Properties
RHP
$8.69B
$457K 0.27%
12,400
– –
2013 Q2
29 quarters
WPC icon
53
W.P. Carey
WPC
$14.8B
$391K 0.23%
6,126
– –
2017 Q3
12 quarters
ALIM icon
54
DELISTED
Alimera Sciences
ALIM
$390K 0.23%
80,194
– –
2017 Q3
12 quarters
CTVA icon
55
Corteva
CTVA
$8.59B
$361K 0.21%
12,545
– –
2019 Q2
5 quarters
CCXI icon
56
DELISTED
ChemoCentryx, Inc.
CCXI
$361K 0.21%
6,587
-68,446
-91% -$3.69M
2019 Q3
4 quarters
CAG icon
57
Conagra Brands
CAG
$6.91B
$357K 0.21%
10,000
– –
2017 Q3
12 quarters
VRCA icon
58
Verrica Pharmaceuticals
VRCA
$61.8M
$357K 0.21%
4,613
+3,118
+209% +$255K
2019 Q2
5 quarters
MIC icon
59
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$354K 0.21%
13,150
– –
2014 Q2
25 quarters
CYTK icon
60
Cytokinetics
CYTK
$8.61B
$343K 0.2%
15,837
+6,914
+77% +$162K
2020 Q2
1 quarter
KRYS icon
61
Krystal Biotech
KRYS
$9.37B
$305K 0.18%
7,079
– –
2018 Q4
7 quarters
MSFT icon
62
Microsoft
MSFT
$3.93T
$294K 0.17%
1,400
– –
2013 Q2
29 quarters
ADMA icon
63
ADMA Biologics
ADMA
$2.39B
$156K 0.09%
65,157
-135,000
-67% -$370K
2020 Q1
2 quarters
FSBW icon
64
FS Bancorp
FSBW
$353M
$147K 0.09%
7,154
– –
2018 Q4
7 quarters
GMED icon
65
Globus Medical
GMED
$10.3B
$144K 0.08%
2,900
– –
2019 Q1
6 quarters
IBB icon
66
iShares Biotechnology ETF
IBB
$10.3B
$135K 0.08%
+1,000
New +$136K
2020 Q3
0 quarters
TARA icon
67
Protara Therapeutics
TARA
$137M
$134K 0.08%
7,948
+4,113
+107% +$95.4K
2020 Q1
2 quarters
KHC icon
68
The Kraft Heinz Company
KHC
$28.1B
$127K 0.07%
4,234
– –
2015 Q3
20 quarters
LEGH icon
69
Legacy Housing
LEGH
$651M
$123K 0.07%
9,000
– –
2018 Q4
7 quarters
ALXO icon
70
ALX Oncology
ALXO
$147M
$113K 0.07%
+3,000
New +$118K
2020 Q3
0 quarters
RLMD icon
71
Relmada Therapeutics
RLMD
$331M
$113K 0.07%
3,000
– –
2020 Q2
1 quarter
MDT icon
72
Medtronic
MDT
$121B
$109K 0.06%
1,050
– –
2014 Q3
24 quarters
SSB icon
73
SouthState Bank Corp
SSB
$9.9B
$101K 0.06%
2,082
– –
2020 Q2
1 quarter
TTE icon
74
TotalEnergies
TTE
$201B
$98K 0.06%
2,860
– –
2013 Q2
29 quarters
CUZ icon
75
Cousins Properties
CUZ
$4.55B
$96K 0.06%
3,357
– –
2015 Q1
22 quarters
1 2
3
4 5

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q3 2020 Portfolio in Review

As of Q3 2020, David M. Knott held 104 positions worth $170M, down 7% from $183M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

David M. Knott withdrew a net $12.5M in Q3 2020, closing 4 positions and reducing 10 holdings. Its most notable exit was BELLUS Health Inc., an estimated $2.47M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 45% a quarter earlier, followed by Financials and Industrials.

Against the trend, David M. Knott opened a new position in Vapotherm, Inc. Common Stock worth $1.42M.

  • David M. Knott's largest Q3 2020 buy was Vapotherm, Inc. Common Stock: 6,125 shares worth $1.42M.
  • David M. Knott added most to TG Therapeutics in Q3 2020, an estimated $892K increase.
  • David M. Knott's biggest Q3 2020 reduction was Stericycle Inc, cutting an estimated $6.7M.
  • David M. Knott fully exited BELLUS Health Inc. in Q3 2020, selling an estimated $2.47M.
  • David M. Knott's ten largest holdings make up 61% of its $170M portfolio in Q3 2020.
  • David M. Knott opened 11 new positions and closed 4 in Q3 2020.
  • David M. Knott's portfolio value fell 7% quarter-over-quarter to $170M.

Based on David M. Knott's 13F filing for Q3 2020, filed 13 Nov 2020.